It can be easy to overlook the importance of early-stage pharmaceutical product development, viewing it as a series of checklist tasks slowing progression toward clinical trials. Rather, early-stage development is critical to establish a solid foundation for those trials.
Success at this point in development means constructing a clear quality target product profile (QTPP) to drive positive proof of concept (PoC) results, all while considering scalability at each step to minimize development challenges downstream.